Virtus ETF Advisers’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
Other funds holding KRON
OFM
VVA
PA
AG
NI
AI
Virtus ETF Advisers's KRON Position: Q2 2022 in Review
Virtus ETF Advisers sold out of Kronos Bio (KRON) in Q2 2022, closing a stake of 11,844 shares — an estimated $86K sold.
Virtus ETF Advisers first reported a position in KRON in Q2 2021 and held it in 4 quarters. The position peaked at $205K in Q2 2021. 93 funds tracked by Wall St. Rank hold KRON as of Q2 2022.
- Virtus ETF Advisers reported no remaining Kronos Bio position as of Q2 2022 after selling out during the quarter.
- Virtus ETF Advisers sold 11,844 Kronos Bio shares in Q2 2022, an estimated $86K.
- Virtus ETF Advisers first reported a position in Kronos Bio in Q2 2021 and held it in 4 quarters.
- Virtus ETF Advisers's Kronos Bio position peaked at $205K in Q2 2021.
- 93 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2022.
Based on Virtus ETF Advisers's 13F filing for Q2 2022, filed 12 Aug 2022.